Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Changes of Bax, Bcl-2, CCR-2, MCP-1, and TGF-β1 genes in the left ventricle of spontaneously hypertensive rat after losartan treatment

  • Lee, Hyeryon (Department of Pediatrics, Ewha Womans University School of College) ;
  • Kim, Kwan Chang (Department of Thoracic and Cardiovascular Surgery, Ewha Womans University School of College) ;
  • Hong, Young Mi (Department of Pediatrics, Ewha Womans University School of College)
  • Received : 2018.08.08
  • Accepted : 2018.10.15
  • Published : 2019.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Increased apoptosis was recently found in the hypertrophied left ventricle of spontaneously hypertensive rats (SHRs). Although the available evidence suggests that apoptosis can be induced in cardiac cells by various insults including pressure overload, cardiac apoptosis appears to result from an exaggerated local production of angiotensin in adult SHRs. Altered expressions of Bcl associated X (Bax), Bcl-2, chemokine receptor (CCR)-2, monocyte chemoattractant protein (MCP)-1, transforming growth factor $(TGF)-{\beta}1$, phosphorylated extracellular signal-regulated kinases (PERK), and connexin 43 proteins, and kallikrein mRNA were investigated to explore the effects of losartan on the SHR model. Methods: Twelve-week-old male rats were grouped as follows: control (C), SHR (hypertension: H), and losartan (L; SHRs were treated with losartan [10 mg/kg/day] for 5 weeks). Western blot and reverse transcription polymerase chain reaction assays were performed. Results: Expression of Bax, CCR-2, MCP-1, $TGF-{\beta}1$, PERK, and connexin 43 proteins, and kallikrein mRNA was significantly increased in the H group compared to that in the C group at weeks 3 and 5. Expression of Bax, CCR-2, MCP-1, $TGF-{\beta}1$, and connexin 43 proteins and kallikrein mRNA was significantly decreased after losartan treatment at week 5. PERK protein expression was significantly decreased after losartan treatment at weeks 3 and 5. Bcl-2 protein expression was significantly decreased in the H group compared to that in the C group at weeks 3 and 5. Conclusion: Losartan treatment reduced expression of Bax, CCR-2, MCP-1, $TGF-{\beta}1$, PERK, and connexin 43 proteins, and kallikrein mRNA in SHRs, along with decreased inflammation and apoptosis.

Keywords

References

  1. Ge L, Zhang G, You B, Cheng G, Chen L, Shi R. The role of losartan in preventing vascular remodeling in spontaneously hypertensive rats by inhibition of the H2O2/VPO1/HOCl/MMPs pathway. Biochem Biophys Res Commun 2017;493:855-61. https://doi.org/10.1016/j.bbrc.2017.06.026
  2. Frieler RA, Mortensen RM. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 2015; 131:1019-30. https://doi.org/10.1161/CIRCULATIONAHA.114.008788
  3. Abbate A, Scarpa S, Santini D, Palleiro J, Vasaturo F, Miller J, et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006;111:371-6. https://doi.org/10.1016/j.ijcard.2005.07.061
  4. Ravassa S, Fortuno MA, Gonzalez A, Lopez B, Zalba G, Fortuno A, et al. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension 2000;36:1065-71. https://doi.org/10.1161/01.HYP.36.6.1065
  5. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007; 74:184-95. https://doi.org/10.1016/j.cardiores.2006.10.002
  6. Halade GV, Jin YF, Lindsey ML. Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther 2013;139:32-40. https://doi.org/10.1016/j.pharmthera.2013.03.009
  7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-97. https://doi.org/10.1152/ajpcell.00287.2006
  8. Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, Vazquez CM. Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond) 2010; 7:21. https://doi.org/10.1186/1476-9255-7-21
  9. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38(3 Pt 2):581-7. https://doi.org/10.1161/hy09t1.096249
  10. Rizzi E, Ceron CS, Guimaraes DA, Prado CM, Rossi MA, Gerlach RF, et al. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and $TGF-{\beta}$ in renovascular hypertension-induced cardiac hypertrophy. Exp Mol Pathol 2013;94:1-9. https://doi.org/10.1016/j.yexmp.2012.10.010
  11. Hong J, Kim K, Kim JH, Park Y. The role of endoplasmic reticulum stress in cardiovascular disease and exercise. Int J Vasc Med 2017; 2017:2049217.
  12. Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 2010;107:839-50. https://doi.org/10.1161/CIRCRESAHA.110.224766
  13. Kirchhoff S, Kim JS, Hagendorff A, Thonnissen E, Kruger O, Lamers WH, et al. Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res 2000; 87:399-405. https://doi.org/10.1161/01.RES.87.5.399
  14. Bonde MM, Olsen KB, Erikstrup N, Speerschneider T, Lyngso C, Haunso S, et al. The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling. Regul Pept 2011;167:21-5. https://doi.org/10.1016/j.regpep.2010.11.003
  15. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91:161-70. https://doi.org/10.1161/01.CIR.91.1.161
  16. Harwani SC, Chapleau MW, Legge KL, Ballas ZK, Abboud FM. Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension. Circ Res 2012;111:1190-7. https://doi.org/10.1161/CIRCRESAHA.112.277475
  17. Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med 2011;13:e11. https://doi.org/10.1017/S1462399411001815
  18. Nguyen Dinh Cat A, Touyz RM. Cell signaling of angiotensin II on vascular tone: novel mechanisms. Curr Hypertens Rep 2011;13:122-8. https://doi.org/10.1007/s11906-011-0187-x
  19. Yao HL, Gao FH, Li ZZ, Wu HX, Xu MD, Zhang Z, et al. Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2. Mol Cell Biochem 2012;366:355-62. https://doi.org/10.1007/s11010-012-1315-x
  20. Gilbert J, Lekstrom-Himes J, Donaldson D, Lee Y, Hu M, Xu J, et al. Effect of CC chemokine receptor 2 CCR2 blockade on serum C- reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region. Am J Cardiol 2011;107:906-11. https://doi.org/10.1016/j.amjcard.2010.11.005
  21. Schiffrin EL. Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 2002;113:409-18. https://doi.org/10.1016/S0002-9343(02)01241-X
  22. Cha JH, Lee HR, Kim KC, Cho MS, Hong YM. Changes of gene expressions in spontaneously hypertensive rat model after losartan treatment. Korean Circ J 2012;42:761-8. https://doi.org/10.4070/kcj.2012.42.11.761
  23. Fortuno MA, Ravassa S, Etayo JC, Diez J. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan. Hypertension 1998;32:280-6. https://doi.org/10.1161/01.HYP.32.2.280
  24. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res 2004;94:1203-10. https://doi.org/10.1161/01.RES.0000126924.23467.A3
  25. Weber KS, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 1999;19:2085-93. https://doi.org/10.1161/01.ATV.19.9.2085
  26. Zhou AX, Tabas I. The UPR in atherosclerosis. Semin Immunopathol 2013;35:321-32. https://doi.org/10.1007/s00281-013-0372-x
  27. Ceravolo GS, Montezano AC, Jordao MT, Akamine EH, Costa TJ, Takano AP, et al. An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies. PLoS One 2014;9: e111117. https://doi.org/10.1371/journal.pone.0111117
  28. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 2002;105:2296-302. https://doi.org/10.1161/01.CIR.0000016049.86468.23
  29. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-56. https://doi.org/10.1161/01.RES.62.4.749
  30. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997;29(1 Pt 2):340-9. https://doi.org/10.1161/01.HYP.29.1.340
  31. Gonzalez A, Lopez B, Ravassa S, Querejeta R, Larman M, Diez J, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002;39:75-80. https://doi.org/10.1161/hy0102.100788

Cited by

  1. Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 C vol.24, pp.3, 2019, https://doi.org/10.3390/molecules24030414